Impact of the COVID-19 situation on aspects of participants’ glycaemic management (past month)*, overall and by diabetes type
| …has been much harder | …has been somewhat harder | …has not been impacted | …has been somewhat easier | …has been much easier | P value† | |
| Affording my rent and other living expenses… | ||||||
| Overall (n=667) | 59 (8.85) | 103 (15.44) | 491 (73.61) | 12 (1.80) | 2 (0.30) | 0.08 |
| T1DM (n=120) | 13 (10.83) | 23 (19.17) | 83 (69.17) | 1 (0.83) | 0 | |
| T2DM (n=547) | 46 (8.41) | 80 (14.63) | 408 (74.59) | 11 (2.01) | 2 (0.37) | |
| Making sure I have enough food to avoid hypoglycaemia… | ||||||
| Overall (n=667) | 54 (8.10) | 130 (19.49) | 475 (71.21) | 7 (1.05) | 1 (0.15) | 0.29 |
| T1DM (n=120) | 8 (6.67) | 20 (16.67) | 91 (75.83) | 1 (0.83) | 0 | |
| T2DM (n=547) | 46 (8.41) | 110 (20.11) | 384 (70.20) | 6 (1.10) | 1 (0.18) | |
| Affording my diabetes medication(s)… | ||||||
| Overall (n=667) | 53 (7.95) | 71 (10.64) | 534 (80.06) | 5 (0.75) | 4 (0.60) | 0.71 |
| T1DM (n=120) | 10 (8.33) | 10 (8.33) | 99 (82.50) | 1 (0.83) | 0 | |
| T2DM (n=547) | 43 (7.86) | 61 (11.15) | 435 (79.52) | 4 (0.73) | 4 (0.73) | |
| Affording my test strips and/or sensors… | ||||||
| Overall (n=667) | 42 (6.30) | 74 (11.09) | 540 (80.96) | 5 (0.75) | 6 (0.90) | 0.38 |
| T1DM (n=120) | 9 (7.50) | 7 (5.83) | 103 (85.83) | 1 (0.83) | 0 | |
| T2DM (n=547) | 33 (6.03) | 67 (12.25) | 437 (79.89) | 4 (0.73) | 6 (1.10) | |
| Getting my diabetes medication(s) from the pharmacy… | ||||||
| Overall (n=667) | 58 (8.70) | 125 (18.74) | 470 (70.46) | 8 (1.20) | 6 (0.90) | 0.24 |
| T1DM (n=120) | 13 (10.83) | 24 (20.00) | 82 (68.33) | 1 (0.83) | 0 | |
| T2DM (n=547) | 45 (8.23) | 101 (18.46) | 388 (70.93) | 7 (1.28) | 6 (1.10) | |
| Consulting with my healthcare provider(s) about my diabetes… | ||||||
| Overall (n=667) | 85 (12.74) | 158 (23.69) | 410 (61.47) | 13 (1.95) | 1 (0.15) | 0.75 |
| T1DM (n=120) | 14 (11.67) | 28 (23.33) | 76 (63.33) | 2 (1.67) | 0 | |
| T2DM (n=547) | 71 (12.98) | 130 (23.77) | 334 (61.06) | 11 (2.01) | 1 (0.18) | |
| Testing/monitoring my blood glucose… | ||||||
| Overall (n=667) | 34 (5.10) | 72 (10.79) | 551 (82.61) | 7 (1.05) | 3 (0.45) | <0.001‡ |
| T1DM (n=120) | 4 (3.33) | 2 (1.67) | 110 (91.67) | 4 (3.33) | 0 | |
| T2DM (n=547) | 30 (5.48) | 70 (12.80) | 441 (80.62) | 3 (0.55) | 3 (0.55) | |
| Remembering to take my diabetes medication(s) as prescribed… | ||||||
| Overall (n=667) | 26 (3.90) | 65 (9.75) | 554 (83.06) | 18 (2.70) | 4 (0.60) | 0.047‡ |
| T1DM (n=120) | 1 (0.83) | 7 (5.83) | 109 (90.83) | 3 (2.50) | 0 | |
| T2DM (n=547) | 25 (4.57) | 58 (10.60) | 445 (81.35) | 15 (2.74) | 4 (0.73) | |
| Monitoring my risk of hypoglycaemia regularly… | ||||||
| Overall (n=667) | 29 (4.35) | 51 (7.65) | 561 (84.11) | 23 (3.45) | 3 (0.45) | 0.026‡ |
| T1DM (n=120) | 3 (2.50) | 6 (5.00) | 103 (85.83) | 8 (6.67) | 0 | |
| T2DM (n=547) | 26 (4.75) | 45 (8.23) | 458 (83.73) | 15 (2.74) | 3 (0.55) | |
| Staying as physically active as I usually am… | ||||||
| Overall (n=667) | 100 (14.99) | 209 (31.33) | 329 (49.33) | 23 (3.45) | 6 (0.90) | 0.84 |
| T1DM (n=120) | 21 (17.50) | 36 (30.00) | 55 (45.83) | 7 (5.83) | 1 (0.83) | |
| T2DM (n=547) | 79 (14.44) | 173 (31.63) | 274 (50.09) | 16 (2.93) | 5 (0.91) | |
| Feeling in control of my hypoglycaemia… | ||||||
| Overall (n=667) | 35 (5.25) | 62 (9.30) | 528 (79.16) | 35 (5.25) | 7 (1.05) | 0.50 |
| T1DM (n=120) | 5 (4.17) | 9 (7.50) | 99 (82.50) | 6 (5.00) | 1 (0.83) | |
| T2DM (n=547) | 30 (5.48) | 53 (9.69) | 429 (78.43) | 29 (5.30) | 6 (1.10) | |
| Having enough social support to help me manage my hypoglycaemia… | ||||||
| Overall (n=667) | 41 (6.15) | 83 (12.44) | 518 (77.66) | 21 (3.15) | 4 (0.60) | 0.056 |
| T1DM (n=120) | 3 (2.50) | 10 (8.33) | 104 (86.67) | 3 (2.50) | 0 | |
| T2DM (n=547) | 38 (6.95) | 73 (13.35) | 414 (75.69) | 18 (3.29) | 4 (0.73) | |
n (%) are presented.
*Data collected from 21 to 28 April 2020.
†Item responses were compared between individuals with T1DM and T2DM. P values were computed using two-sample Wilcoxon-Mann-Whitney tests.
‡Statistically significant at α=0.05 (ie, the underlying distributions of item responses statistically significantly differed by diabetes type).
T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus.